Goldman Sachs
LABD icon

Goldman Sachs’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Goldman Sachs’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Buy
302,923
+243,715
+412% +$3.28M ﹤0.01% 4552
2026
Q1 		$965K Buy
+59,208
New +$1.12M ﹤0.01% 5111
2025
Q4 		– Sell
-5,324
Closed -$215K – 6662
2025
Q3 		$215K Buy
5,324
+88
+2% +$5.1K ﹤0.01% 5920
2025
Q2 		$392K Buy
+5,236
New +$463K ﹤0.01% 5305
2025
Q1 		– Sell
-1,171
Closed -$84.9K – 6258
2024
Q4 		$84.9K Sell
1,171
-2,932
-71% -$179K ﹤0.01% 5788
2024
Q3 		$240K Buy
4,103
+310
+8% +$18.8K ﹤0.01% 5388
2024
Q2 		$278K Buy
3,793
+233
+7% +$19.7K ﹤0.01% 5140
2024
Q1 		$259K Sell
3,560
-17,754
-83% -$1.48M ﹤0.01% 5025
2023
Q4 		$2.07M Sell
21,314
-10,989
-34% -$2.14M ﹤0.01% 3903
2023
Q3 		$6.65M Buy
32,303
+23,419
+264% +$3.8M ﹤0.01% 2741
2023
Q2 		$1.28M Buy
8,884
+3,804
+75% +$568K ﹤0.01% 4183
2023
Q1 		$1.05M Buy
5,080
+545
+12% +$92.6K ﹤0.01% 4348
2022
Q4 		$782K Buy
+4,535
New +$929K ﹤0.01% 4585
2022
Q3 		– Sell
-958
Closed -$373K – 6422
2022
Q2 		$373K Sell
958
-1,321
-58% -$662K ﹤0.01% 5284
2022
Q1 		$799K Sell
2,279
-734
-24% -$288K ﹤0.01% 5002
2021
Q4 		$776K Buy
+3,013
New +$693K ﹤0.01% 5058
2018
Q1 		– Sell
-8
Closed -$71K – 6167
2017
Q4 		$71K Hold
8
– – ﹤0.01% 5846
2017
Q3 		$70K Hold
8
– – ﹤0.01% 6173
2017
Q2 		$106K Buy
+8
New +$154K ﹤0.01% 6098

Other funds holding LABD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

Goldman Sachs's LABD Position: Q2 2026 in Review

Goldman Sachs increased its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 412% in Q2 2026, buying an estimated $3.28M and bringing the position to 302,923 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #4552.

Goldman Sachs first reported a position in LABD in Q2 2017 and has held it in 19 quarters since. The position peaked at $6.65M in Q3 2023. 21 funds tracked by Wall St. Rank hold LABD as of Q2 2026.

  • Goldman Sachs held 302,923 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $2.34M as of Q2 2026.
  • Goldman Sachs bought 243,715 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2026, an estimated $3.28M.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4552 holding.
  • Goldman Sachs first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2017 and has held it in 19 quarters since.
  • Goldman Sachs's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $6.65M in Q3 2023.
  • 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.